annual D&A:
$233.00K+$115.00K(+97.46%)Summary
- As of today (September 18, 2025), CDTX annual depreciation & amortization is $233.00 thousand, with the most recent change of +$115.00 thousand (+97.46%) on December 31, 2024.
- During the last 3 years, CDTX annual D&A has risen by +$44.00 thousand (+23.28%).
- CDTX annual D&A is now -68.17% below its all-time high of $732.00 thousand, reached on December 31, 2016.
Performance
CDTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$27.00K-$22.00K(-44.90%)Summary
- As of today (September 18, 2025), CDTX quarterly depreciation & amortization is $27.00 thousand, with the most recent change of -$22.00 thousand (-44.90%) on June 30, 2025.
- Over the past year, CDTX quarterly D&A has dropped by -$30.00 thousand (-52.63%).
- CDTX quarterly D&A is now -96.88% below its all-time high of $866.00 thousand, reached on December 31, 2020.
Performance
CDTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$196.00K-$30.00K(-13.27%)Summary
- As of today (September 18, 2025), CDTX TTM depreciation & amortization is $196.00 thousand, with the most recent change of -$30.00 thousand (-13.27%) on June 30, 2025.
- Over the past year, CDTX TTM D&A has increased by +$22.00 thousand (+12.64%).
- CDTX TTM D&A is now -88.38% below its all-time high of $1.69 million, reached on September 30, 2021.
Performance
CDTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CDTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +97.5% | -52.6% | +12.6% |
| 3 y3 years | +23.3% | +112.3% | +111.7% |
| 5 y5 years | -29.0% | -55.7% | +113.1% |
CDTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +97.5% | -55.7% | +112.3% | -15.9% | +110.1% |
| 5 y | 5-year | -29.0% | +97.5% | -96.9% | +101.3% | -88.4% | +110.1% |
| alltime | all time | -68.2% | >+9999.0% | -96.9% | +101.3% | -88.4% | +110.1% |
CDTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $27.00K(-44.9%) | $196.00K(-13.3%) |
| Mar 2025 | - | $49.00K(-16.9%) | $226.00K(-3.0%) |
| Dec 2024 | $233.00K(+97.5%) | $59.00K(-3.3%) | $233.00K(+9.4%) |
| Sep 2024 | - | $61.00K(+7.0%) | $213.00K(+22.4%) |
| Jun 2024 | - | $57.00K(+1.8%) | $174.00K(+22.5%) |
| Mar 2024 | - | $56.00K(+43.6%) | $142.00K(+20.3%) |
| Dec 2023 | $118.00K(-17.5%) | $39.00K(+77.3%) | $118.00K(+9.3%) |
| Sep 2023 | - | $22.00K(-12.0%) | $108.00K(-12.2%) |
| Jun 2023 | - | $25.00K(-21.9%) | $123.00K(-200.8%) |
| Mar 2023 | - | $32.00K(+10.3%) | -$122.00K(-185.3%) |
| Dec 2022 | $143.00K(-24.3%) | $29.00K(-21.6%) | $143.00K(-107.4%) |
| Sep 2022 | - | $37.00K(-116.8%) | -$1.94M(+15.2%) |
| Jun 2022 | - | -$220.00K(-174.1%) | -$1.68M(+40.6%) |
| Mar 2022 | - | $297.00K(-114.5%) | -$1.20M(-2.8%) |
| Dec 2021 | $189.00K(-33.9%) | -$2.05M(-802.4%) | -$1.23M(-172.9%) |
| Sep 2021 | - | $292.00K(+9.8%) | $1.69M(+15.6%) |
| Jun 2021 | - | $266.00K(+1.1%) | $1.46M(+16.3%) |
| Mar 2021 | - | $263.00K(-69.6%) | $1.25M(+19.4%) |
| Dec 2020 | $286.00K(-12.8%) | $866.00K(+1253.1%) | $1.05M(-169.8%) |
| Sep 2020 | - | $64.00K(+4.9%) | -$1.50M(+0.7%) |
| Jun 2020 | - | $61.00K(+3.4%) | -$1.50M(+0.7%) |
| Mar 2020 | - | $59.00K(-103.5%) | -$1.48M(+7.1%) |
| Dec 2019 | $328.00K | -$1.69M(-2382.4%) | -$1.39M(-433.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $74.00K(+2.8%) | $415.00K(-13.2%) |
| Jun 2019 | - | $72.00K(-54.4%) | $478.00K(-11.8%) |
| Mar 2019 | - | $158.00K(+42.3%) | $542.00K(+3.6%) |
| Dec 2018 | $523.00K(-21.6%) | $111.00K(-19.0%) | $523.00K(-5.1%) |
| Sep 2018 | - | $137.00K(+0.7%) | $551.00K(-1.3%) |
| Jun 2018 | - | $136.00K(-2.2%) | $558.00K(-8.2%) |
| Mar 2018 | - | $139.00K(0.0%) | $608.00K(-8.8%) |
| Dec 2017 | $667.00K(-8.9%) | $139.00K(-3.5%) | $667.00K(-6.5%) |
| Sep 2017 | - | $144.00K(-22.6%) | $713.00K(-4.6%) |
| Jun 2017 | - | $186.00K(-6.1%) | $747.00K(-0.5%) |
| Mar 2017 | - | $198.00K(+7.0%) | $751.00K(+2.6%) |
| Dec 2016 | $732.00K(+58.8%) | $185.00K(+3.9%) | $732.00K(+1.8%) |
| Sep 2016 | - | $178.00K(-6.3%) | $719.00K(+12.2%) |
| Jun 2016 | - | $190.00K(+6.1%) | $641.00K(+16.8%) |
| Mar 2016 | - | $179.00K(+4.1%) | $549.00K(+19.1%) |
| Dec 2015 | $461.00K(+157.5%) | $172.00K(+72.0%) | $461.00K(+21.6%) |
| Sep 2015 | - | $100.00K(+2.0%) | $379.00K(+8.6%) |
| Jun 2015 | - | $98.00K(+7.7%) | $349.00K(+29.3%) |
| Mar 2015 | - | $91.00K(+1.1%) | $270.00K(+50.8%) |
| Dec 2014 | $179.00K(>+9900.0%) | $90.00K(+28.6%) | $179.00K(+101.1%) |
| Sep 2014 | - | $70.00K(+268.4%) | $89.00K(+368.4%) |
| Jun 2014 | - | $19.00K(>+9900.0%) | $19.00K(>+9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00 | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual D&A year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Cidara Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM D&A year-on-year change?
What is Cidara Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of CDTX is $233.00K
What is the all time high annual D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual depreciation & amortization is $732.00K
What is Cidara Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, CDTX annual depreciation & amortization has changed by +$115.00K (+97.46%)
What is Cidara Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of CDTX is $27.00K
What is the all time high quarterly D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly depreciation & amortization is $866.00K
What is Cidara Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, CDTX quarterly depreciation & amortization has changed by -$30.00K (-52.63%)
What is Cidara Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of CDTX is $196.00K
What is the all time high TTM D&A for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM depreciation & amortization is $1.69M
What is Cidara Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, CDTX TTM depreciation & amortization has changed by +$22.00K (+12.64%)